• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环吡酮胺阴道给药于兔和患者后的药代动力学

Pharmacokinetics of ciclopirox olamine after vaginal application to rabbits and patients.

作者信息

Coppi G, Silingardi S, Girardello R, De Aloysio D, Manzardo S

机构信息

Pharmacological and Toxicological Department, Poli Industria Chimica, Rozzano, Milan, Italy.

出版信息

J Chemother. 1993 Oct;5(5):302-6. doi: 10.1080/1120009x.1993.11755468.

DOI:10.1080/1120009x.1993.11755468
PMID:8106903
Abstract

The authors reported the plasma levels and pharmacokinetic parameters of ciclopirox olamine in rabbits after i.v. and intravaginal administrations and in female patients after vaginal administration. Plasma levels of total and free ciclopirox were determined by a HPLC method. In rabbit ciclopirox showed a half-life of 2.22 h and an intravaginal bioavailability of about 2%. In female patients ciclopirox showed low intravaginal absorption; this value might explain the good local and systemic tolerability and also the penetration of drug in deep tissue.

摘要

作者报告了静脉注射和阴道给药后兔体内环吡酮胺的血浆水平和药代动力学参数,以及阴道给药后女性患者体内的相关情况。采用高效液相色谱法测定总环吡酮和游离环吡酮的血浆水平。在兔体内,环吡酮的半衰期为2.22小时,阴道生物利用度约为2%。在女性患者中,环吡酮的阴道吸收较低;这一数值可能解释了其良好的局部和全身耐受性,以及药物在深部组织中的渗透情况。

相似文献

1
Pharmacokinetics of ciclopirox olamine after vaginal application to rabbits and patients.环吡酮胺阴道给药于兔和患者后的药代动力学
J Chemother. 1993 Oct;5(5):302-6. doi: 10.1080/1120009x.1993.11755468.
2
HPLC method for pharmacokinetic studies on ciclopirox olamine in rabbits after intravenous and intravaginal administrations.静脉注射和阴道给药后兔体内环吡酮胺药代动力学研究的高效液相色谱法
Farmaco. 1992 May;47(5 Suppl):779-86.
3
Pharmacokinetics of Ciclopirox Olamine after Buccal Administration in Rabbits.环吡酮胺在兔口腔给药后的药代动力学
Curr Drug Deliv. 2017;14(1):99-108. doi: 10.2174/1567201813666160502142856.
4
Local tolerance of a new ciclopirox olamine vaginal preparation in rats and rabbits.新型环吡酮胺阴道制剂在大鼠和兔体内的局部耐受性
J Chemother. 1993 Oct;5(5):307-12. doi: 10.1080/1120009x.1993.11739250.
5
Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies.口服环吡酮胺在晚期血液恶性肿瘤患者的 I 期研究中表现出生物活性。
Am J Hematol. 2014 Apr;89(4):363-8. doi: 10.1002/ajh.23640. Epub 2014 Mar 3.
6
[Pharmacokinetics and biotransformation of the antimycotic drug ciclopiroxolamine in animals and man after topical and systemic administration].
Arzneimittelforschung. 1981;31(8A):1337-53.
7
The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy.将抗真菌药物环吡酮胺重新定位为治疗血液恶性肿瘤的新型治疗药物。
J Clin Pharm Ther. 2011 Apr;36(2):128-34. doi: 10.1111/j.1365-2710.2010.01172.x. Epub 2010 Aug 24.
8
Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.1%环吡酮胺洗剂:与1%环吡酮胺乳膏的生物等效性及足癣临床疗效
Clin Ther. 1989 May-Jun;11(3):290-303.
9
Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.环吡酮胺外用制剂的研发:药物释放、渗透及皮肤滞留的评估
Pharm Dev Technol. 2015 Mar;20(2):197-203. doi: 10.3109/10837450.2013.860544. Epub 2013 Nov 29.
10
Skin uptake and clearance of ciclopirox following topical application.经皮应用后环吡酮胺的皮肤摄取和清除。
Biopharm Drug Dispos. 2013 Dec;34(9):540-9. doi: 10.1002/bdd.1866.

引用本文的文献

1
Repurposing of Ciclopirox to Overcome the Limitations of Zidovudine (Azidothymidine) against Multidrug-Resistant Gram-Negative Bacteria.重新利用环吡酮以克服齐多夫定(叠氮胸苷)对多重耐药革兰氏阴性菌的局限性。
Pharmaceutics. 2022 Mar 1;14(3):552. doi: 10.3390/pharmaceutics14030552.
2
Breast intraductal nanoformulations for treating ductal carcinoma in situ II: Dose de-escalation using a slow releasing/slow bioconverting prodrug strategy.用于治疗原位导管癌的乳腺腔内纳米制剂 II:使用缓释/慢生物转化前药策略进行剂量下调。
Drug Deliv Transl Res. 2022 Jan;12(1):240-256. doi: 10.1007/s13346-021-00903-y. Epub 2021 Feb 15.
3
Sugar and iron: Toward understanding the antibacterial effect of ciclopirox in Escherichia coli.
糖与铁:解析环吡酮胺在大肠杆菌中抗菌作用的机制。
PLoS One. 2019 Jan 11;14(1):e0210547. doi: 10.1371/journal.pone.0210547. eCollection 2019.
4
Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use.pH 值对光滑念珠菌和白念珠菌体外药敏的影响及其对临床应用的意义。
Antimicrob Agents Chemother. 2012 Mar;56(3):1403-6. doi: 10.1128/AAC.05025-11. Epub 2012 Jan 9.
5
Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.环吡酮胺:作为一种局部抗真菌药物,其近期的非临床和临床数据。
Drugs. 2010 Nov 12;70(16):2133-52. doi: 10.2165/11538110-000000000-00000.